Back to search

Article

Non-Myelotoxic Agents as a Preparatory Regimen for Hematopoietic Stem Cell Gene Therapy

2023-07-18

Abstract excerpt

<title>Abstract</title> <p>RAG2 deficiency is characterized by a lack of B and T lymphocytes, causing severe lethal infections. Currently, RAG2 deficiency is treated with a Hematopoietic Stem Cell transplantation (HSCT). Most conditioning regimens used before HSCT consist of alkylating myelotoxic agents with or without irradiation and affect growth and development of pediatric patients. Here, we developed a non-m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ffa18ecd-a778-5e24-ac8a-2c689b926c3f
DOI
10.21203/rs.3.rs-3067174/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Non-Myelotoxic Agents as a Preparatory Regimen for Hematopoietic Stem Cell Gene TherapyDOI 10.21203/rs.3.rs-3067174/v1
Select a neighboring publication to make it the new centre.